Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains

Abstract

This provides an objective methodology to localize risk within specific biological endophenotypes and drill down into the most significantly associated sets of GO terms and annotated genes for potential therapeutic targets.